Neurofibromatosis type 2 (NF2): screening and surveillance
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Neurofibromatosis type 2 (NF2): screening and surveillance. Pre-symptomatic NF2 family members. Fully referenced neurology checklist.
Genetic screening: indications
- Pre-symptomatic NF2 family members
- Unilateral vestibular schwannoma
- Multiple meningiomas under the age of 30 years
- Spinal schwannomas
Annual clinical surveillance
Locked: subscribe to see this section.
Magnetic resonance imaging (MRI): brain surveillance
Locked: subscribe to see this section.
Magnetic resonance imaging (MRI): spinal surveillance
Locked: subscribe to see this section.
Synonym
Locked: subscribe to see this section.
References
- Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol 2007; 6:340-351.
- Gareth D, Evans R. Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis 2009; 4:16.
- Evans DGR, Salvador H, Chang VY, et al. Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 2 and related disorders. Clin Cancer Res 2017; 23:e54-e61.
